Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner (Q43704044)

26 November 2017

title

Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner (English)

1 reference

26 November 2017

1 reference

26 November 2017

Pedro-Botet J

1 reference

26 November 2017

Schaefer EJ

1 reference

26 November 2017

Bakker-Arkema RG

1 reference

26 November 2017

Black DM

1 reference

26 November 2017

Stein EM

1 reference

26 November 2017

Corella D

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

158

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

183-193

1 reference

Primary and secondary prevention of coronary artery disease: a follow-up on clinical controlled trials

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Lovastatin Decreases De Novo Cholesterol Synthesis and LDL Apo B-100 Production Rates in Combined-Hyperlipidemic Males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

A brief review paper of the efficacy and safety of atorvastatin in early clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Atorvastatin, a New HMG-CoA Reductase Inhibitor as Monotherapy and Combined With Colestipol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Genes, variation of cholesterol and fat intake and serum lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Apolipoprotein E polymorphism and plasma cholesterol response to probucol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Influence of apolipoprotein E polymorphism on bezafibrate treatment response in dyslipidemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

A simple salting out procedure for extracting DNA from human nucleated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Comparison of statins in hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

The genetics of serum lipid responsiveness to dietary interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900410-5

10.1016/S0021-9150(01)00410-5

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference